Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1274 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
PLERIXAFOR
Not marketed
Renal Impairment
AMD31001101NANCT00445302Tabulated Results
PLERIXAFOR
Not marketed
Transplantation
AMD31002112NANCT00396331Tabulated Results
PLERIXAFOR
Mozobil
Non-Hodgkin's Lymphoma or Hodgkin's Disease
AMD31002113NANCT00444912Tabulated Results
PLERIXAFOR
Mozobil
Non-Hodgkin's Lymphoma
AMD31003101NANCT00103610Tabulated Results
PLERIXAFOR
Mozobil
Multiple Myeloma
AMD31003102NANCT00103662Tabulated Results
PLERIXAFOR
Mozobil
Multiple Myeloma or Non-Hodgkin's Lyjmphoma
AMD3100C201NANCT00396266Tabulated Results
PLERIXAFOR
Mozobil
Multiple Myeloma or Non-Hodgkin's Lyjmphoma
AMD3100EU21NANCT00322842Tabulated Results
PLERIXAFOR
Mozobil
Multiple Myeloma
ARD12858-MOZ23510NAEudraCT: 2011-004783-30Tabulated Results
PLERIXAFOR
Mozobil
Non-Hodgkin's Lymphoma
EFC12482NANCT01767714Summary
PLERIXAFOR
Mozobil
Non-Hodgkin's Lymphoma
MOZ11809NANCT01164475Tabulated Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted